Lipoprotein lipase in diabetes

Diabetes/Metabolism Reviews

Volumn 3, Issue 2, 1987, Pages 551-570

  Taskinen, Marja‐Riitta ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN LIPASE; SULFONYLUREA;

ADULT; ENDOCRINE SYSTEM; ETIOLOGY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

DIABETES MELLITUS; HUMAN; LIPOPROTEIN LIPASE; SUPPORT, NON-U.S. GOV'T;

EID: 0023126669     PISSN: 07424221     EISSN: 10990895     Source Type: Journal    
DOI: 10.1002/dmr.5610030208     Document Type: Article

References (92)

1. HDL in relation to the metabolism of triglyceride‐rich lipoproteins
2. 2‐like particles during lipolysis of very low density lipoproteins in vitro
3. Plasma high‐density lipoproteins
4. Changes in plasma lipoprotein particles after heparin‐induced lipolysis in hypertriglyceridemic subjects
5. In vitro catabolism of human plasma very low density lipoproteins
6. 3 levels by lipoprotein lipase
7. Lipolytic enzymes and plasma lipoprotein metabolism
8. Tissue lipoprotein lipase activity and its action in lipoprotein metabolism
9. Lipoprotein lipase: mechanism of action and role in lipoprotein metabolism
10. The lipoprotein lipase system
11. Comparison of the triglyceride lipase of liver, adipose tissue and postheparin plasma
12. Separation and characterization of two triglyceride lipase activities from human postheparin plasma
13. 2—phospholipids and triglycerides by hepatic lipase
14. Human postheparin plasma hepatic lipase activity against triacylglycerol and phospholipid substrates
15. Triacylglycerol lipase, monoacylglycerol lipase and phospholipase activities of highly purified rat hepatic lipase
16. Metabolic and endocrine control of plasma high density lipoprotein concentration. Relation to catabolism of triglyceride‐rich lipoproteins
17. Regulation of lipoprotein metabolism by endothelial lipolytic enzymes
18. Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia
19. An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma
20. Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase
21. 1
22. Rapid determination of lipoprotein lipase activity in human adipose tissue
23. A method for determining lipoprotein‐lipase activity in human adipose tissue
24. A micromethod for assay of lipoprotein lipase activity in needle biopsy samples of adipose tissue and skeletal muscle
25. Lipoprotein‐lipase activity in human skeletal muscle and adipose tissue in the fasting and the fed states
26. 1–3
27. Rapid effects of lipoprotein lipase activity in adipose tissue of humans after carbohydrate and lipid intake. Time course and relation to plasma glycerol, triglyceride and insulin levels
28. Lipoprotein lipase of adipose tissue and skeletal muscle in human obesity: response to glucose and to semistarvation
29. Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique
30. The relationship between the basal lipolytic and lipoprotein lipase activities in human adipose tissue
31. Serum lipoprotein and lipoprotein lipase in overweight, Type II diabetics during and after supplemented fasting
32. Regulation of lipoprotein lipase induction by insulin
33. Effect of nutritional status on rat adipose tissue, muscle and postheparin plasma clearing factor lipase activities: their relationship to triglyceride fatty add uptake by fat‐cells and to plasma insulin concentrations
34. Insulin regulation of lipoprotein lipase in altered isolated rat adipocytes
35. Insulin regulation of fat cell ribosomes, protein synthesis, and lipoprotein lipase
36. Lipoprotein lipase and uptake of chylomicron triglyceride by skeletal muscle of rats
37. The significance of lipoprotein lipase in rat skeletal muscles
38. Is the hypertriglyceridemia associated with insulin deficiency caused by decreased lipoprotein lipase activity?
39. The effect of hormones on lipoprotein lipase activity in skeletal muscles of the rat
40. Lipoprotein lipase activity in adipose tissue and skeletal muscle in runners: relation to serum lipoproteins
41. Diabetic lipemia. A form of acquired fat‐induced lipemia
42. Acute insulin withdrawal and the regulation of plasma triglyceride removal in diabetic subjects
43. Lipoprotein lipase activity in patients with diabetes mellitus, with and without hyperlipemia
44. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relation to plasma triglyceride metabolism
45. Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin‐deficient human diabetes
46. Lipoprotein lipase activity in adipose tissue and skeletal muscle of human diabetics during insulin deprivation and restoration
47. Serum lipids and lipoproteins in insulin‐treated diabetes. Demonstration of increased high density lipoprotein concentrations
48. High density lipoproteins in diabetes
49. Regulation of HDL, and its subfractions in chronically insulin treated patients with type 1 diabetes
50. Site of insulin resistance in Type 1 diabetes: insulin‐mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro
51. Plasma lipid and lipoprotein abnormalities in diabetes
52. The effects of diabetic acidosis and coma upon the serum lipoproteins and cholesterol
53. Plasma triglyceride and fatty acid metabolism in diabetes mellitus
54. Effects of insulin on plasma lipoproteins in diabetic ketoacidosis: evidence for a change in high density lipoprotein composition during treatment
55. Plasma triglyceride transport kinetics in diabetes mellitus
56. The effect of strict control with the artificial β‐cell on plasma lipid levels in insulin‐dependent diabetes
57. The effect of continuous subcutaneous insulin infusion on very‐low‐density lipoprotein triglyceride metabolism in Type I diabetes mellitus
58. High density lipoprotein subfractions in insulin‐dependent diabetic and normal subjects
59. High density lipoprotein composition in insulin‐dependent diabetes mellitus
60. Apolipoprotein B levels and altered lipoprotein composition in diabetes
61. Evidence for a new cause of defective plasma removal of very low density lipoproteins in insulin‐deficient rats
62. Lipoprotein lipase activity and uptake of exogenous triglycerides in fat cells of different size
63. Effect of fat cell size, restrictive diet and diabetes on lipoprotein lipase release of human adipose tissue
64. Determinants of human adipose tissue lipoprotein lipase
65. Etude de l'activite au niveau du tissu apideux humain: Influence de l'obesite et du diabete
66. Lipoprotein lipase activity in adipose tissue and in postheparin plasma in human obesity
67. Adipose tissue lipoprotein‐lipase activity in obesity
68. Lipoprotein lipase activity in adipose tissue from obese human beings
69. Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity
70. Lipoprotein lipase activity of adipose tissue, skeletal muscle and postheparin plasma in primary endogenous hypertriglyceri‐daemia: relation to lipoprotein pattern and to obesity
71. Evidence for diabetes mellitus and genetic forms of hypertriglyceridemia as independent entities
72. Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus
73. Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes)
74. The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non‐insulin‐dependent diabetic subjects without familial hypertriglyceridemia
75. Lipoprotein lipase activity of human adipose tissue in health and in some diseases with hyperlipidemia as a common feature
76. Insulin‐independent diabetes: a defect in the activity of lipoprotein lipase in adipose tissue
77. Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin‐independent) diabetes associated with obesity
78. The lipoprotein‐lipase activity of adipose tissue from different sites in obese women and relationship to cell size
79. Site differences in the basal metabolism of subcutaneous fat in obese women
80. Lipoprotein lipase activity and adiposity in the Pima Indians‐a study of three different fat depots
81. Site differences in insulin receptor binding and insulin action in subcutaneous fat of obese females
82. Effect of treatment on the concentration of lipoproteins and the postheparin‐lipolytic activity in the plasma of noninsulin‐dependent diabetics
83. Improvement of the plasma lipoprotein pattern after institution of insulin treatment in diabetes mellitus
84. Mechanism of hypertriglyceridemia in diabetic patients with fasting hyperglycaemia
85. Diabetic hypertriglyceridemia. Evidence for three clinical syndromes
86. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein‐B kinetics in non‐insulin‐dependent diabetes mellitus
87. Abnormal lipoprotein‐lipase‐mediated plasma triglyceride removal in untreated diabetes mellitus associated with hypertriglyceridemia
88. The effect of sulfonylurea therapy on plasma lipids and high density lipoprotein composition in non‐insulin‐dependent diabetics1